Addex Therapeutics Ltd Stock
Stocks
ADXN
CH0029850754
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Swiss Exchange
03:30:15 07/11/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 0.0208 CHF | -7.96% |
|
-7.96% | -62.45% |
| 09/10 | Swiss Market Index Retreats; Novartis Shares Decline | MT |
| 08/10 | Addex Therapeutics' Neurosterix to Advance Schizophrenia Drug to Phase 2 Trials | MT |
| Market Cap | 4.58M 5.59M 5.02M 4.18M 7.88M 526M 8.13M 55.26M 22.03M 281M 20.99M 20.54M 886M | P/E 2024 |
0.8x | P/E 2025 | -0.88x |
|---|---|---|---|---|---|
| Enterprise Value | 2.98M 3.64M 3.26M 2.72M 5.13M 342M 5.29M 35.93M 14.33M 182M 13.65M 13.36M 576M | EV / Sales 2024 |
5.67x | EV / Sales 2025 | 28.1x |
| Free-Float |
60.59% | Yield 2024 * |
-
| Yield 2025 | - |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| ADXN | Delayed | |
Deutsche Boerse AG
| APE | Delayed | |
|
CBOE
| 0QNV | Real-time | |
|
Börse Stuttgart
| APE | Delayed | |
|
Boerse Muenchen
| APE | Real-time |
Last Transcript: Addex Therapeutics Ltd
| 1 day | -7.96% | ||
| 1 week | -7.96% | ||
| Current month | -7.96% | ||
| 1 month | -7.14% | ||
| 3 months | -46.39% | ||
| 6 months | -56.67% | ||
| Current year | -62.45% |
| 1 week | 0.02 |  | 0.02 |
| 1 month | 0.02 | | 0.02 |
| Current year | 0.02 | | 0.07 |
| 1 year | 0.02 | | 0.07 |
| 3 years | 0.02 | | 0.26 |
| 5 years | 0.02 | | 1.3 |
| 10 years | 0.02 | | 4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tim Dyer
CEO | Chief Executive Officer | 58 | 01/06/2013 |
Lénaic Teyssédou
DFI | Director of Finance/CFO | 40 | 01/06/2017 |
Roger Mills
CTO | Chief Tech/Sci/R&D Officer | 69 | 28/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Vincent Lawton
CHM | Chairman | 77 | - |
Tim Dyer
BRD | Director/Board Member | 58 | 01/01/2015 |
Ray Hill
BRD | Director/Board Member | 81 | 12/05/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/9/26 | Issuer sale | Chief Technology Officer | -885,674 | 0.4051% | ||
| 2/9/26 | Issuer sale | Director | -539,122 | 0.2466% | ||
| 2/9/26 | Issuer sale | Chief Financial Officer | -1,205,816 | 0.5515% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.96% | -7.96% | -65.79% | -58.40% | 5.59M | |
| -4.83% | +3.51% | +53.62% | +61.75% | 65.94B | |
| -1.34% | +2.98% | +24.79% | +100.18% | 56.53B | |
| +0.02% | +1.07% | +10.63% | +76.66% | 56.88B | |
| +5.09% | +9.89% | +22.45% | +107.48% | 46.49B | |
| +2.62% | +1.68% | +28.91% | +37.01% | 44.8B | |
| +8.24% | +0.51% | +213.26% | +792.66% | 41.59B | |
| -1.86% | +10.13% | +26.82% | +53.22% | 35.35B | |
| -2.97% | -9.84% | +88.86% | +76.17% | 33.29B | |
| -2.18% | +7.06% | +36.06% | -4.95% | 24.92B | |
| Average | -0.52% | +2.13% | +43.96% | +124.18% | 40.58B | |
| Weighted average by Cap. | +0.21% | +3.40% | +53.12% | +142.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 410K 500K 449K 374K 705K 47.02M 727K 4.94M 1.97M 25.09M 1.88M 1.84M 79.21M | 173K 211K 189K 158K 297K 19.82M 307K 2.08M 831K 10.58M 792K 775K 33.39M |
| Net income | 7.06M 8.61M 7.72M 6.44M 12.14M 809M 12.52M 85.05M 33.91M 432M 32.31M 31.62M 1.36B | -6.73M -8.21M -7.36M -6.14M -11.57M -772M -11.94M -81.1M -32.34M -412M -30.81M -30.15M -1.3B |
| Net Debt | -3.3M -4.03M -3.61M -3.01M -5.68M -378M -5.85M -39.77M -15.86M -202M -15.11M -14.79M -637M | -1.6M -1.96M -1.76M -1.46M -2.76M -184M -2.85M -19.33M -7.71M -98.15M -7.34M -7.19M -310M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/11/26 | CHF 0.0208 | -7.96% | 765,087 |
| 05/11/26 | CHF 0.0226 | +2.73% | 73,917 |
| 04/11/26 | CHF 0.0220 | +2.80% | 1,463,010 |
| 03/11/26 | CHF 0.0214 | -5.31% | 211,911 |
| 02/11/26 | CHF 0.0226 | 0.00% | 58,222 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ADXN Stock
Select your edition
All financial news and data tailored to specific country editions
